Search research articles

Search research articles

Related Experiment Videos

AIDS Cholangiopathy.

Tony E. Yusuf¹, Todd H. Baron

¹Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. Baron.Todd@mayo.edu

Current Treatment Options in Gastroenterology

|March 11, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025

Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023

Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023

Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023

Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023

Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

AIDS cholangiopathy, a serious complication of advanced AIDS, is often caused by opportunistic infections. Treatment focuses on highly active antiretroviral therapy and interventions for biliary obstruction.

Area of Science:

Gastroenterology
Infectious Diseases
Hepatology

Background:

Acquired immunodeficiency syndrome (AIDS) can lead to fatal systemic and infectious complications.
AIDS cholangiopathy presents with right upper quadrant/midepigastric pain, cholestasis, and cholangitis symptoms.
Opportunistic infections, particularly Cryptosporidium and cytomegalovirus, are the primary causes of AIDS cholangiopathy.

Purpose of the Study:

To outline the diagnostic and therapeutic strategies for AIDS cholangiopathy.
To highlight the common causes and clinical presentations of AIDS cholangiopathy.

Main Methods:

Review of clinical presentations and diagnostic findings in AIDS cholangiopathy.
Discussion of endoscopic retrograde cholangiopancreatography (ERCP) findings, including papillary stenosis and sclerosing cholangitis.

Related Experiment Videos

Evaluation of treatment modalities, including antimicrobial therapy, highly active antiretroviral therapy (HAART), ursodeoxycholic acid, endoscopic procedures, and surgery.

Main Results:

Four distinct cholangiographic abnormalities are identified via ERCP, with papillary stenosis and sclerosing cholangitis being most common.
Antimicrobial therapy is frequently ineffective for AIDS cholangiopathy.
Highly active antiretroviral therapy (HAART) improves immune function and is the most effective medical treatment for clearing opportunistic infections.

Conclusions:

AIDS cholangiopathy requires prompt diagnosis and intervention.
While antimicrobial therapy has limited efficacy, HAART offers the best medical management by addressing underlying opportunistic infections.
Endoscopic interventions like sphincterotomy, balloon dilation, and stenting, along with cholecystectomy and celiac plexus block, provide symptomatic relief and manage biliary complications.